165 related articles for article (PubMed ID: 34233525)
1. Megestrol acetate drives endometrial carcinoma cell senescence via interacting with progesterone receptor B/FOXO1 axis.
Wang H; Shi H
Exp Biol Med (Maywood); 2021 Nov; 246(21):2307-2316. PubMed ID: 34233525
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells.
Diep CH; Charles NJ; Gilks CB; Kalloger SE; Argenta PA; Lange CA
Cell Cycle; 2013 May; 12(9):1433-49. PubMed ID: 23574718
[TBL] [Abstract][Full Text] [Related]
3. Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.
Diep CH; Knutson TP; Lange CA
Mol Cancer Res; 2016 Feb; 14(2):141-62. PubMed ID: 26577046
[TBL] [Abstract][Full Text] [Related]
4. Roles of SIRT1/FoxO1/SREBP-1 in the development of progestin resistance in endometrial cancer.
Wang Y; Zhang L; Che X; Li W; Liu Z; Jiang J
Arch Gynecol Obstet; 2018 Nov; 298(5):961-969. PubMed ID: 30206735
[TBL] [Abstract][Full Text] [Related]
5. The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma.
Ward EC; Hoekstra AV; Blok LJ; Hanifi-Moghaddam P; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ
Endocrinology; 2008 Apr; 149(4):1942-50. PubMed ID: 18096667
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor signaling pathway involved in progestin-resistance of human endometrial carcinoma: In a mouse model.
Xu Y; Tong J; Ai Z; Wang J; Teng Y
J Obstet Gynaecol Res; 2012 Dec; 38(12):1358-66. PubMed ID: 22612393
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
Zhao S; Chen X; Lu X; Yu Y; Feng Y
Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435
[TBL] [Abstract][Full Text] [Related]
8. Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer.
Wen W; Lowe G; Roberts CM; Finlay J; Han ES; Glackin CA; Dellinger TH
Sci Rep; 2017 Oct; 7(1):12754. PubMed ID: 28986550
[TBL] [Abstract][Full Text] [Related]
9. A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer.
Pautier P; Vergote I; Joly F; Melichar B; Kutarska E; Hall G; Lisyanskaya A; Reed N; Oaknin A; Ostapenko V; Zvirbule Z; Chetaille E; Geniaux A; Shoaib M; Green JA
Int J Gynecol Cancer; 2017 Feb; 27(2):258-266. PubMed ID: 27870712
[TBL] [Abstract][Full Text] [Related]
10. 5-aza-2'-deoxycytidine improves the sensitivity of endometrial cancer cells to progesterone therapy.
Hu Q; Yu L; Chen R; Wang YL; Ji L; Zhang Y; Xie Y; Liao QP
Int J Gynecol Cancer; 2012 Jul; 22(6):951-9. PubMed ID: 22683940
[TBL] [Abstract][Full Text] [Related]
11. [Functional study of progesterone receptor isoforms in endometrial cancer cell lines].
Lu Y; Liao QP; Chen CL; Yu L
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):475-9. PubMed ID: 17068617
[TBL] [Abstract][Full Text] [Related]
12. Ligand activated progesterone receptor B drives autophagy-senescence transition through a Beclin-1/Bcl-2 dependent mechanism in human breast cancer cells.
De Amicis F; Guido C; Santoro M; Giordano F; Donà A; Rizza P; Pellegrino M; Perrotta I; Bonofiglio D; Sisci D; Panno ML; Tramontano D; Aquila S; Andò S
Oncotarget; 2016 Sep; 7(36):57955-57969. PubMed ID: 27462784
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modification restores functional PR expression in endometrial cancer cells.
Yang S; Xiao X; Jia Y; Liu X; Zhang Y; Wang X; Winters CJ; Devor EJ; Meng X; Thiel KW; Leslie KK
Curr Pharm Des; 2014; 20(11):1874-80. PubMed ID: 23888956
[TBL] [Abstract][Full Text] [Related]
14. Medroxyprogesterone acetate stimulates cdk inhibitors, p21 and p27, in endometrial carcinoma cells transfected with progesterone receptor-B cDNA.
Kawaguchi M; Watanabe J; Hamano M; Kamata Y; Arai T; Nishimura Y; Obokata A; Jobo T; Kuramoto H
Eur J Gynaecol Oncol; 2006; 27(1):33-8. PubMed ID: 16550965
[TBL] [Abstract][Full Text] [Related]
15. Absence of progesterone receptors in a failed case of fertility-sparing treatment in early endometrial cancer: a case report.
Hoekstra AV; Kim JJ; Keh P; Schink JC
J Reprod Med; 2008 Nov; 53(11):869-73. PubMed ID: 19097521
[TBL] [Abstract][Full Text] [Related]
16. Progestin treatment decreases CD133+ cancer stem cell populations in endometrial cancer.
Guy MS; Qamar L; Behbakht K; Post MD; Sheeder J; Sartorius CA; Spillman MA
Gynecol Oncol; 2016 Mar; 140(3):518-26. PubMed ID: 26731726
[TBL] [Abstract][Full Text] [Related]
17. PGRMC1 Regulates Cellular Senescence via Modulating FOXO1 Expression in Decidualizing Endometrial Stromal Cells.
Tsuru A; Yoshie M; Kojima J; Yonekawa R; Azumi M; Kusama K; Nishi H; Tamura K
Biomolecules; 2022 Jul; 12(8):. PubMed ID: 36008941
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy outcome in patients with stage 1a endometrial adenocarcinoma, who conservatively treated with megestrol acetate.
Shirali E; Yarandi F; Eftekhar Z; Shojaei H; Khazaeipour Z
Arch Gynecol Obstet; 2012 Mar; 285(3):791-5. PubMed ID: 21805142
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional cross talk between the forkhead transcription factor forkhead box O1A and the progesterone receptor coordinates cell cycle regulation and differentiation in human endometrial stromal cells.
Takano M; Lu Z; Goto T; Fusi L; Higham J; Francis J; Withey A; Hardt J; Cloke B; Stavropoulou AV; Ishihara O; Lam EW; Unterman TG; Brosens JJ; Kim JJ
Mol Endocrinol; 2007 Oct; 21(10):2334-49. PubMed ID: 17609436
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and progesterone receptor expression of decidual endometrium in a postmenopausal woman treated with tamoxifen and megestrol acetate.
Cohen I; Shulman A; Altaras M; Tepper R; Cordoba M; Beyth Y
Gynecol Obstet Invest; 1994; 38(2):127-9. PubMed ID: 7959340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
